For years, prediabetes has been treated like a warning sign, a yellow light before the red signal of type 2 diabetes. The advice has been familiar, lose weight, eat better, move more, and monitor blood sugar. However, while this guidance is still valuable, emerging research is beginning to challenge a deeper assumption, what if we are already late by the time we diagnose prediabetes?
Interestingly, this shift in thinking is not just academic. It has real implications for how we screen, treat, and even define metabolic health.
Prediabetes May Start Earlier Than We Think
Traditionally, prediabetes is diagnosed based on specific lab thresholds,
• Fasting glucose: 100–125 mg/dL
• HbA1c: 5.7%–6.4%
However, recent studies suggest that metabolic dysfunction begins well before these numbers are reached. In fact, subtle insulin resistance, impaired glucose handling, and early pancreatic beta cell stress can already be present in people who still fall within “normal” ranges.
From a physiological perspective, this makes sense. The body does not suddenly become insulin resistant overnight. Instead, it’s a gradual process involving inflammation, lipid accumulation, and hormonal imbalance. As a result, by the time blood sugar rises enough to meet diagnostic criteria, the underlying damage may already be underway.
Moreover, some researchers have proposed a new concept: an early transitional phase before prediabetes, sometimes informally referred to as “pre-prediabetes.” While not yet an official diagnosis, it highlights an important idea, our current screening tools may be catching the problem too late in its trajectory.
The Weight Loss Centric Model Is Being Questioned
For decades, one of the strongest recommendations for prediabetes has been weight loss. Undoubtedly, excess body weight is a major risk factor. However, new evidence suggests the story is more nuanced.
Notably, clinical studies have shown that individuals can improve insulin sensitivity and glucose control even without significant weight loss. Structured lifestyle interventions, such as balanced diets, increased physical activity, and improved sleep, can lead to measurable metabolic improvements independent of the number on the scale.
This means that weight loss, while helpful, may not be the only indicator of progress. In other words, metabolic health and body weight are related but not identical.
For example,
• A person may lose weight but still have poor insulin sensitivity
• Conversely, another may maintain weight but improve glucose control through dietary quality and exercise
Therefore, this shift is especially important in clinical practice, where focusing solely on weight can sometimes discourage patients. A broader, more flexible approach may improve both outcomes and long-term adherence.
A New Goal (From Prevention to Remission)
Traditionally, the goal in prediabetes has been to delay or prevent progression to type 2 diabetes. Now, however, some experts are advocating for something more ambitious: remission.
Prediabetes remission refers to restoring glucose levels back to a normal range, such as,
• Fasting glucose below 100 mg/dL
• HbA1c below 5.7%
Importantly, this concept reframes prediabetes as a potentially reversible condition rather than an inevitable pathway.
Supporting this, long term studies show that individuals who normalize their blood glucose levels experience significantly lower risks of cardiovascular disease, kidney complications, and mortality.
In simple terms, the earlier we intervene, and the more effectively we do so, the greater the chance of reversing the process.
Personalized Metabolism (One Size Does Not Fit All)
At the same time, another important development is the recognition that prediabetes is not a single uniform condition.
In reality, two people with the same blood sugar levels may have completely different underlying issues,
• One may have predominant insulin resistance in muscle tissue
• Another may have impaired insulin secretion from the pancreas
• A third may have abnormal liver glucose production
Because of this variability, some individuals respond well to certain diets or exercise plans, while others do not.
Fortunately, advances in technology, such as continuous glucose monitoring (CGM), are helping uncover these differences. By tracking real time glucose responses to meals, sleep, and activity, clinicians can begin to design personalized interventions rather than relying on generalized advice.
Ultimately, this is where medicine is heading: precision lifestyle therapy, guided by individual metabolic responses rather than population averages.
Why Early Intervention Matters Beyond Diabetes
While prediabetes is often viewed as a precursor to diabetes, its impact extends much further.
Even mildly elevated blood glucose levels are associated with,
• Increased risk of heart disease
• Early vascular damage
• Chronic inflammation
• Cognitive decline over time
In fact, some studies suggest that improving glucose control in prediabetes can reduce cardiovascular risk by nearly 50%. That’s a substantial benefit, especially at such an early stage.
This clearly shows that prediabetes is not harmless. Rather, it is an active metabolic state with real consequences, even before diabetes develops.
What This Means in Practice
So, what does all this mean in real world care?
First, it suggests that we need to rethink screening. Waiting for glucose levels to cross a diagnostic threshold may not be enough. Instead, looking at trends over time, family history, waist circumference, and lifestyle patterns can provide earlier clues.
Second, treatment should be multidimensional. Rather than focusing only on weight loss, it is more effective to prioritize,
• Improving dietary quality (fiber, protein, healthy fats)
• Encouraging regular physical activity
• Supporting sleep and stress management
• Monitoring metabolic markers beyond glucose alone
Third, patient communication plays a critical role. When prediabetes is framed as reversible rather than inevitable, it can motivate meaningful lifestyle changes.
The Takeaway
Overall, the emerging science around prediabetes tells a compelling story. This condition is not a simple stepping stone to diabetes; instead, it is a dynamic, early-stage metabolic disturbance that begins long before we formally recognize it.
Consequently, the traditional model, diagnose late, focus on weight loss, aim to slow progression, is gradually being replaced by a more proactive approach:
detect earlier, treat more precisely, and aim for reversal.
From a pharmacist’s perspective, this shift is encouraging. It reflects a move toward care that is not only more scientifically grounded but also more empowering for patients.
In the end, the body rarely fails suddenly. It sends signals, quiet, gradual, and often overlooked. The real opportunity lies in recognizing those signals early and acting before they evolve into disease.
FAQs
Q1. Can prediabetes really be reversed?
Yes, in many cases prediabetes can be reversed. Research shows that improving diet quality, increasing physical activity, and addressing sleep and stress can bring blood glucose levels back to normal ranges. Importantly, remission is possible even without major weight loss in some individuals, depending on their metabolic profile.
Q2. If my blood sugar is “normal,” should I still be concerned?
Possibly. Emerging evidence suggests that metabolic changes like insulin resistance can begin before blood sugar crosses diagnostic thresholds. This means a person may appear “normal” on lab tests but still have early metabolic dysfunction, especially if risk factors like family history, central obesity, or sedentary lifestyle are present.
Call to Action
If you or your patients fall into the prediabetes range, or even have risk factors, don’t wait for numbers to worsen. Start early with small, consistent lifestyle changes. Focus on metabolic health, not just weight. Early action today can prevent long term complications tomorrow.
Disclaimer
This content is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, and personalized medical guidance.
References
• Lancet (Cardiovascular Outcomes Study), Shows normalization of glucose significantly reduces heart disease risk.
• Diabetes Prevention Program (DPP), Landmark trial demonstrating lifestyle changes reduce progression to diabetes.
• Nature Reviews Endocrinology, Highlights early insulin resistance and beta-cell dysfunction before prediabetes diagnosis.
• American Diabetes Association (ADA), Provides diagnostic criteria and management guidelines for prediabetes.
• EASD (European Association for the Study of Diabetes), Supports individualized and precision based metabolic care approaches
